Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19
- PMID: 32479920
- PMCID: PMC7256552
- DOI: 10.1053/j.ajkd.2020.05.002
Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19
Figures
References
-
- WHO Novel coronavirus – China. 2020. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/
-
- ArcGIS Dashboards. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594...
-
- Chawla L.S., Krishnan M. Causes and consequences of inflammation on anemia management in hemodialysis patients. Hemodial Int. 2009;13(2):222–234. - PubMed
-
- Chen N., Hao C., Liu B.C. Roxadustat treatment for anemia in patients undergoing long-term dialysis. N Engl J Med. 2019;381(11):1011–1022. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
